Clinical Aspects of Type 3 Long-QT Syndrome
Author(s) -
Arthur A.M. Wilde,
Arthur J. Moss,
Elizabeth S. Kaufman,
Wataru Shimizu,
Derick R. Peterson,
Jesaia Benhorin,
Coeli M. Lopes,
Jeffrey A. Towbin,
Carla Spazzolini,
Lia Crotti,
Wojciech Zaręba,
Ilan Goldenberg,
Jørgen K. Kanters,
Jennifer L. Robinson,
Ming Qi,
Nynke Hofman,
David J. Tester,
Connie R. Bezzina,
Mariëlle Alders,
Takeshi Aiba,
Shiro Kamakura,
Yoshihiro Miyamoto,
Mark Andrews,
Scott McNitt,
Bronislava Polonsky,
Peter J. Schwartz,
Michael J. Ackerman
Publication year - 2016
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.116.021823
Subject(s) - medicine , long qt syndrome , qt interval , population , sudden death , sudden cardiac death , proportional hazards model , cardiology , logistic regression , environmental health
Risk stratification in patients with type 3 long-QT syndrome (LQT3) by clinical and genetic characteristics and effectiveness of β-blocker therapy has not been studied previously in a large LQT3 population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom